Which Laser Systems Are Recommended For Deep Dermal Pigmented Lesions Such As Nevus Of Ota And Abnom (Hori's Nevus), And What Treatment Protocols Should Be Anticipated? Top Devices & Protocols

For deep dermal lesions such as Nevus of Ota and ABNOM, short-pulsed Q-switched lasers are the standard treatment choice. The main options are Q-switched 1064 nm Nd:YAG, 755 nm Alexandrite, and 694 nm Ruby lasers. Because the pigment is deep in the dermis, treatment usually requires multiple sessions, with Nevus of Ota commonly needing approximately 4–8 treatments and ABNOM often showing a somewhat lower response rate with more frequent transient post-inflammatory hyperpigmentation.

The deeper and darker the dermal pigment, the stronger the rationale for Q-switched 1064 nm Nd:YAG. Alexandrite and Ruby lasers can be effective when pigment is more superficial or in appropriately selected lighter skin types, but all options require staged treatment, conservative follow-up, and careful management of dyspigmentation risk.

Why Q-switched lasers are recommended

They target pigment without removing skin

Q-switched lasers deliver very short, high-peak-power pulses that fragment melanin through a predominantly photoacoustic effect. This selectively disrupts dermal pigment while minimizing thermal injury to surrounding tissue.

That makes them preferable to ablative CO₂ or Er:YAG lasers, which vaporize tissue and carry a greater risk of scarring, particularly when treating broad facial lesions.

Deep dermal pigment needs sufficient penetration

The depth of the melanocytes determines which wavelength is most appropriate.

1064 nm Nd:YAG: Generally preferred for deeper blue-black or dark brown lesions because it penetrates further and is commonly favored for darker skin types.
755 nm Alexandrite: Useful for selected dermal pigment, particularly when the lesion is less deeply situated and the patient has a lighter skin type.
694 nm Ruby: Effective for suitable pigmented lesions and may clear some cases with fewer sessions, but has a relatively greater concern for hypopigmentation.

Choosing the system by lesion and patient factors

Nevus of Ota

Nevus of Ota contains melanocytic cells deep within the dermis, often across cosmetically sensitive facial areas. Q-switched 1064 nm Nd:YAG is usually the most broadly applicable option, especially for deep pigment or darker skin.

Q-switched Alexandrite or Ruby may be considered when the pigment is more superficial and the patient’s skin type makes those wavelengths appropriate.

ABNOM, or Hori’s Nevus

ABNOM is also treated with multiple sessions using Q-switched Nd:YAG, Alexandrite, or Ruby lasers. However, practitioners should set expectations differently from Nevus of Ota.

ABNOM may show a slightly lower response rate and a higher incidence of transient post-inflammatory hyperpigmentation, so treatment planning should emphasize gradual clearance and careful pigment-risk assessment.

Picosecond systems

Picosecond Nd:YAG or Alexandrite systems may also be used in some practices, but the strongest conventional recommendation remains short-pulsed Q-switched treatment. The specific device, pulse duration, fluence, and session interval should be selected according to lesion depth, skin type, and the clinician’s validated protocol.

What treatment protocol should be anticipated?

Expect multiple treatment sessions

Patients should not expect complete clearance after one procedure.

Nevus of Ota: Commonly requires approximately 4–8 sessions, although the total may vary.
ABNOM: Usually requires multiple sessions and may respond less predictably than Nevus of Ota.
More extensive or resistant lesions: May need additional treatments beyond these typical ranges.

Clearance is gradual because pigment fragments must be cleared biologically after laser disruption.

Sessions are spaced apart

An initial interval of approximately 6–8 weeks is commonly used to allow inflammation, pigment fragmentation, and early cellular clearance to settle.

As the lesion lightens and treatment fluence is increased, intervals may be extended to several months. Some protocols therefore use intervals of approximately 3–4 months, particularly later in the treatment course or when delayed pigment clearance and dyspigmentation risk are concerns.

Treatment parameters are individualized

For deep lesions treated with 1064 nm Nd:YAG, treatment commonly begins with the largest practical spot size and a fluence close to the patient’s maximum tolerated level, while remaining within the device’s validated safety parameters.

The goal is effective pigment disruption without excessive epidermal or dermal injury. Exact settings cannot be safely standardized across devices because spot size, pulse width, cooling, skin type, and lesion characteristics all alter the delivered energy.

Clinical endpoints differ by wavelength

With Q-switched Ruby and Alexandrite lasers, the expected endpoint is generally immediate whitening of the treated pigment.

With Q-switched 1064 nm Nd:YAG, deep lesions may show less dramatic immediate whitening. Delayed pinpoint bleeding can occur several minutes after treatment and may be an expected endpoint when appropriate energy has reached the deeper pigment.

The endpoint must be interpreted by an experienced clinician rather than used as a stand-alone measure of treatment success.

What patients should be counseled about

Pigment changes are the main practical risk

Transient post-inflammatory hyperpigmentation is particularly important in ABNOM and in patients with darker skin types.

Hypopigmentation, purpura, and uneven clearance are also possible. These risks support conservative parameter selection, adequate intervals, and careful reassessment before each session.

Some areas respond better than others

Cheek and temple lesions may respond more readily than lesions involving the eyelids. Patients should also understand that scleral pigmentation associated with Nevus of Ota cannot be cleared with cutaneous laser treatment.

Eye protection is essential

Ocular safety is critical when treating lesions near the eyelids or lash line. Appropriate protective measures, including metal eye shields placed over the globe when indicated, are necessary for periocular treatment.

Anesthesia is often not required

Q-switched treatment is non-ablative and is often performed without local anesthesia, although comfort measures may be considered according to the treatment area and patient tolerance.

The absence of tissue vaporization does not eliminate risk; improper parameters can still cause burns, scarring, or persistent dyspigmentation.

Understanding the Trade-offs

Nd:YAG offers depth and broader skin-type utility

The 1064 nm Nd:YAG laser is usually the most practical choice for deep dermal pigment and darker skin types. Its trade-off is that clearance may be slower and the immediate clinical endpoint less visually obvious than with shorter wavelengths.

Ruby may clear efficiently but has greater pigment risk

Q-switched Ruby can be effective and may require fewer sessions in some cases. However, its higher risk of hypopigmentation makes patient selection and conservative treatment particularly important.

Alexandrite sits between depth and selectivity

Q-switched Alexandrite can be useful for selected lesions and lighter skin types. It is less suitable than 1064 nm Nd:YAG when the pigment is very deep or the patient has a higher baseline risk of adverse pigmentary change.

More sessions are safer than excessive energy

Attempting to accelerate clearance with overly aggressive fluence can increase the risk of scarring, prolonged inflammation, purpura, and permanent dyspigmentation.

The central treatment trade-off is gradual clearance with controlled injury versus faster treatment that may produce unacceptable pigment complications.

Making the Right Choice for Your Goal

The final device and protocol should be confirmed by a clinician experienced in dermal melanocytic lesions and laser treatment across different skin types.

If your primary focus is deep Nevus of Ota pigment: A Q-switched 1064 nm Nd:YAG system is generally the leading option, with multiple sessions and approximately 6–8-week initial intervals that may later lengthen.
If your primary focus is ABNOM: Anticipate multiple Q-switched Nd:YAG, Alexandrite, or Ruby treatments, with counseling that response may be less consistent and transient hyperpigmentation more common.
If your primary focus is lighter skin with relatively superficial dermal pigment: Q-switched Alexandrite or Ruby may be considered, provided the clinician accepts and manages the higher dyspigmentation risk.
If your primary focus is minimizing scarring: Favor non-ablative Q-switched treatment rather than ablative CO₂ or Er:YAG resurfacing for broad facial lesions.
If your primary focus is periocular safety: Ensure that appropriate ocular protection and an experienced laser operator are used, while recognizing that scleral pigmentation is not treated by cutaneous laser.

With realistic expectations, staged treatment, and wavelength selection based on pigment depth and skin type, these lesions can often be lightened substantially while minimizing permanent textural and pigmentary complications.

Summary Table:

Laser System	Wavelength (nm)	Suitable for	Typical Sessions	Key Considerations
Q-Switched Nd:YAG	1064	Deep, darker lesions; darker skin types	4-8 for Nevus of Ota; variable for ABNOM	Delayed pinpoint bleeding; slower clearance; broadly applicable for deeper pigment
Q-Switched Alexandrite	755	More superficial dermal pigment; lighter skin types	Multiple sessions	Risk of hypopigmentation; good for selected cases
Q-Switched Ruby	694	More superficial; lighter skin types	Possibly fewer sessions	Higher risk of hypopigmentation; careful patient selection
Picosecond (optional)	755/1064	Emerging option	Variable	Not first-line; require validated protocols

Are you a clinic or premium salon looking to offer the most effective laser treatments for deep pigmented lesions? BELIS offers professional-grade Q-switched Nd:YAG, Alexandrite, and Ruby laser systems, along with picosecond options, all designed for exceptional safety and efficacy. Our advanced technology, combined with comprehensive training and support, helps you achieve optimal patient outcomes and satisfaction. Contact us today to learn more about our laser solutions and how we can help you expand your aesthetic offerings with confidence.